Table 3 Comparison of treatment outcomes between specific drug-containing regimens
| Â | Not exposed | Exposed | p-value | |
|---|---|---|---|---|
Clofazimine-containing regimens | (n = 109) | (n = 25) |  | |
Treatment outcome, n (%) | Cured | 45 (41.3) | 12 (48.0) | 0.13 |
Treatment completed | 44 (40.4) | 8 (32.0) | ||
Died | 4 (3.7) | 4 (16.0) | ||
Default | 9 (8.3) | 1 (4.0) | ||
Transferred out | 7 (6.4) | 0 (0.0) | ||
Linezolid-containing regimens | (n = 88) | (n = 46) |  | |
Treatment outcome, n (%) | Cured | 28 (31.8) | 29 (63.0) | 0.001 |
Treatment completed | 41 (46.6) | 11 (23.9) | 0.01 | |
Died | 4 (4.6) | 4 (8.7) | 0.44 | |
Default | 9 (10.2) | 1 (2.2) | 0.16 | |
Transferred out | 6 (6.8) | 1 (2.2) | 0.42 | |
Meropenem-containing regimens | (n = 89) | (n = 45) |  | |
Treatment outcome, n (%) | Cured | 25 (28.1) | 32 (71.1) | < 0.0001 |
Treatment completed | 44 (49.4) | 8 (17.8) | < 0.0001 | |
Died | 3 (3.4) | 5 (11.1) | 0.12 | |
Default | 10 (11.2) | 0 (0.0) | 0.02 | |
Transferred out | 7 (7.9) | 0 (0.0) | 0.10 | |
Fluoroquinolones-containing regimens | (n = 15) | (n = 119) |  | |
Treatment outcome, n (%) | Cured | 5 (33.3) | 52 (43.7) | 0.33 |
Treatment completed | 8 (53.3) | 44 (37.0) | ||
Died | 2 (13.3) | 6 (5.0) | ||
Default | 0 (0.0) | 10 (8.4) | ||
Transferred out | 0 (0.0) | 7 (5.9) | ||
Amikacin-containing regimens | (n = 69) | (n = 65) |  | |
Treatment outcome, n (%) | Cured | 21 (30.4) | 36 (55.4) | 0.004 |
Treatment completed | 31 (44.9) | 21 (32.3) | 0.13 | |
Died | 4 (5.8) | 4 (6.2) | 1.0 | |
Default | 9 (13.0) | 1 (1.5) | 0.02 | |
Transferred out | 4 (5.8) | 3 (4.6) | 1.0 | |